CONNECT WITH US
HealthTech

HealthTech

How radiation or chemotherapy before bone marrow transplantation may shape human immune system recovery

Medical Xpress logo

Published on

Add as a preferred source on Google
How radiation or chemotherapy before bone marrow transplantation may shape human immune system recovery

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

In a new study from the USC Stem Cell lab of Rong Lu, Ph.D., researchers used genetic barcoding to track individual human blood-forming stem and progenitor cells after transplanting them into mice. The study revealed how different types of human blood-forming cells regenerate the blood and immune system, and how different forms of pretransplant conditioning, a treatment used to prepare a recipient before bone marrow transplantation, affected blood and immune cell recovery.

The findings, published in npj Regenerative Medicine, add to the scientific understanding of human blood and immune cell regeneration and can inform future strategies to optimize bone marrow transplants for patients.

Researchers used genetic barcode-based clonal tracking, which allows them to follow individual cells and their descendants to see how they contribute to blood and immune cell production over time, comparing two cell types: hematopoietic stem cells (HSCs) and multipotent progenitor cells (MPPs). Both HSCs and MPPs can produce multiple types of blood and immune cells, but HSCs are thought to have unique long-term regenerative capacity, based largely on animal studies.

, professor of stem cell biology and regenerative medicine at the Keck School of Medicine of USC, who led the research. She is also a professor of biomedical engineering, medicine and gerontology.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.